|
OMIM |
Link |
Information gain |
01 |
|
lipoprotein types--ld system
|
[NCBI]
|
0.00247056
|
|
|
AN
|
[NCBI]
|
0.00247056
|
|
|
splenic hypoplasia
|
[NCBI]
|
0.00194777
|
|
|
CDAN3
|
[NCBI]
|
0.0015281
|
|
|
IGAD1
|
[NCBI]
|
0.000962915
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.000895892
|
|
|
SPS
|
[NCBI]
|
0.000698643
|
|
|
alport syndrome, autosomal recessive
|
[NCBI]
|
0.000218311
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
0.000209811
|
|
|
ITGA2
|
[NCBI]
|
0.00016218
|
|
|
blood group--en
|
[NCBI]
|
0.00015664
|
|
|
blood group--private systems
|
[NCBI]
|
0.00015664
|
|
|
ART4
|
[NCBI]
|
0.000125613
|
|
|
von willebrand disease, x-linked form
|
[NCBI]
|
0.000125072
|
|
|
t-cell subgroups, non-hla-linked
|
[NCBI]
|
0.000125072
|
|
|
KN
|
[NCBI]
|
0.000125072
|
|
|
surface antigen, glycoprotein 75
|
[NCBI]
|
0.000113172
|
|
|
thrombocytopenia, platelet dysfunction, hemolysis, and imbalanced globin synthesis
|
[NCBI]
|
0.000113172
|
|
|
raph blood group system
|
[NCBI]
|
0.000105452
|
|
|
IN
|
[NCBI]
|
9.97171e-05
|
|
|
giant platelet syndrome
|
[NCBI]
|
9.0347e-05
|
|
|
PMDS
|
[NCBI]
|
8.52838e-05
|
|
|
SC
|
[NCBI]
|
8.52838e-05
|
|
|
THC1
|
[NCBI]
|
8.05108e-05
|
|
|
von willebrand disease, recessive form
|
[NCBI]
|
7.84597e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
7.32449e-05
|
|
|
platelet glycoprotein iv deficiency
|
[NCBI]
|
7.32449e-05
|
|
|
CF
|
[NCBI]
|
5.8884e-05
|
|
|
malaria, susceptibility to
|
[NCBI]
|
5.81702e-05
|
|
|
LU
|
[NCBI]
|
5.37077e-05
|
|
|
von willebrand disease
|
[NCBI]
|
5.19911e-05
|
|
|
THY1
|
[NCBI]
|
5.17578e-05
|
|
|
RHD
|
[NCBI]
|
4.91391e-05
|
|
|
HLA-DQA1
|
[NCBI]
|
4.63042e-05
|
|
|
RA
|
[NCBI]
|
4.54379e-05
|
|
|
neutrophil-specific antigen: nd1
|
[NCBI]
|
4.2952e-05
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
3.62518e-05
|
|
|
SLE
|
[NCBI]
|
3.56244e-05
|
|
|
HLA-A
|
[NCBI]
|
3.45236e-05
|
|
|
PTPRJ
|
[NCBI]
|
3.09122e-05
|
|
|
antigen defined by monoclonal antibody f10.44.2
|
[NCBI]
|
3.09122e-05
|
|
|
neutrophil-specific antigen 1
|
[NCBI]
|
3.09122e-05
|
|
|
hemophilia a
|
[NCBI]
|
2.79671e-05
|
|
|
HPA-2
|
[NCBI]
|
2.75894e-05
|
|
|
HEMB
|
[NCBI]
|
2.69204e-05
|
|
|
ITGAL
|
[NCBI]
|
2.61542e-05
|
|
|
NPTX2
|
[NCBI]
|
2.50251e-05
|
|
|
CD55
|
[NCBI]
|
2.50251e-05
|
|
|
FUT1
|
[NCBI]
|
2.29472e-05
|
|
|
FCGR3A
|
[NCBI]
|
2.23006e-05
|
|
|
MME
|
[NCBI]
|
2.20047e-05
|
|
|
Ge
|
[NCBI]
|
2.17245e-05
|
|
|
MG
|
[NCBI]
|
2.14107e-05
|
|
|
CD8A
|
[NCBI]
|
1.97078e-05
|
|
|
ITGA2B
|
[NCBI]
|
1.97078e-05
|
|
|
COL4A3
|
[NCBI]
|
1.93481e-05
|
|
|
PAI1
|
[NCBI]
|
1.82538e-05
|
|
|
FY
|
[NCBI]
|
1.7718e-05
|
|
|
HLA-DRA
|
[NCBI]
|
1.73495e-05
|
|
|
C4B
|
[NCBI]
|
1.68956e-05
|
|
|
C4A
|
[NCBI]
|
1.6788e-05
|
|
|
RHCE
|
[NCBI]
|
1.6788e-05
|
|
|
ITGB3
|
[NCBI]
|
1.51586e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
1.35132e-05
|
|
|
WAS
|
[NCBI]
|
1.31253e-05
|
|
|
EPO
|
[NCBI]
|
1.14111e-05
|
|
|
MCP
|
[NCBI]
|
9.87101e-06
|
|
|
TPO
|
[NCBI]
|
5.5446e-06
|
|
|
F3
|
[NCBI]
|
5.54084e-06
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
4.37044e-06
|
|
|
IL2
|
[NCBI]
|
4.22729e-06
|
|
|
ALB
|
[NCBI]
|
4.08018e-06
|
|
|
CEACAM5
|
[NCBI]
|
3.50414e-06
|
|
|
TNF
|
[NCBI]
|
3.48378e-06
|
|
|
TNFSF6
|
[NCBI]
|
1.18767e-06
|
|
|
PCNA
|
[NCBI]
|
1.06544e-06
|
|
|
ACHE
|
[NCBI]
|
4.57272e-07
|
|
|
VEGF
|
[NCBI]
|
2.32641e-07
|
|
|
MBP
|
[NCBI]
|
7.55675e-08
|
|
|
HGF
|
[NCBI]
|
5.55124e-08
|
|
|
MPO
|
[NCBI]
|
9.74816e-11
|
|